Health news and discussion on TalkFuse.
Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
A review of 115 clinical trials involving more than 30,000 people found that escitalopram, duloxetine and agomelatine performed better than fluoxetine at helping people with depression remain well over time. The findings may inform treatment choices, but researchers stressed that no one medicine is best for everyone.
The study compared 20 antidepressants using results from earlier trials rather than following a new group of patients. Escitalopram was the strongest performer among the selective serotonin reuptake inhibitors studied; agomelatine carries a risk of liver failure and is not approved in the United States. The researchers and an independent psychiatrist said treatment decisions should weigh personal benefits and side effects, and may include therapy; patients should consult their doctor before changing medication.
In short
- Three medicines outperformed fluoxetine in long-term results.
- The review combined 115 trials and over 30,000 participants.
- Treatment choice depends on individual benefits and side effects.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
The review offers evidence that some medicines may help more people stay well after depression improves, which could help clinicians make better-informed treatment choices. Where a patient’s circumstances and health make them suitable, considering escitalopram, duloxetine or agomelatine could reduce the risk of relapse, alongside attention to side effects and other forms of care.
The case against
The results do not establish one best medicine for every patient: they compare earlier trials, and an average advantage may not predict an individual’s response. Fluoxetine may still be a reasonable choice when it has worked well or better suits someone’s needs, while agomelatine’s liver risks and differences in approval and availability weigh against treating the ranking as a simple reason to switch.
Explained simply
Depression can affect mood, sleep, energy and daily life, and antidepressants are medicines used to help manage it. They work in different ways, and people can respond differently to the same treatment.
Fluoxetine, escitalopram, duloxetine and agomelatine are among the medicines compared in the study. They belong to different groups of antidepressants, and their possible benefits and side effects vary; some medicines also have specific safety risks or restrictions.
Treatment choices can include medication, talking therapy or both. Clinicians consider a person’s health, symptoms, past treatment and preferences, so study findings are one part of deciding what may suit an individual.
Health Medicine Mental Health Research Science World